International Precision Oncology Tumor Board -- MEK inhibition

VIDEO | 02:17:04

In this edition of the Molecular Tumor Board series on precision oncology, global leading experts discuss MEK inhibition in various tumor contexts. The panelists include world-renowned physicians from Medicana International Hospital Group Precision Cancer Center, Acibadem Health Group (Adana Acibadem Hospital), Bhaktivedanta Hospital and Research Institute, and Memorial Sloan Kettering Cancer Center.

This meeting took place on September 20, 2023.